Global competition law saw significant regulatory and judicial activity across multiple jurisdictions throughout June and July 2026, according to Greenberg Traurig’s latest Competition Currents newsletter.
In the United States, a Colorado federal judge temporarily blocked enforcement of the state’s price cap on the arthritis drug Enbrel, manufactured by Amgen, Inc., finding it violated federal patent protections.
Judge Daniel D. Domenico held that the price cap violated the “bargain struck by Congress” in allowing drug patent holders to charge supracompetitive prices while their patents remain enforceable.
AIDS Healthcare Foundation, operator of multiple nonprofit wellness centers, filed suit against pharmacy-benefit manager Express Scripts, alleging its reimbursement practices favour affiliated pharmacies and push independent providers out of the market.
The United States Supreme Court declined to review Monster Energy Co.’s $272 million verdict against Vital Pharmaceuticals and founder Jack Owoc, leaving the judgment intact after the Ninth Circuit affirmed the lower court’s decision.
The DOJ’s Antitrust Division secured commitments from Bayer CropScience LLC to modify its seed loyalty programme, with Acting Assistant Attorney General Omeed Assefi stating that “enforcement in agriculture is a top priority for the Antitrust Division.”
The DOJ also cleared the proposed merger between Paramount and Warner Bros., concluding the deal would not harm competition in streaming video, linear television, or theatrical film production and distribution.
A proposed DOJ settlement with OhioHealth Corporation would void restrictive contracting provisions with commercial health insurers and prohibit similar terms in the future, with five years of compliance monitoring required.
In Mexico, the National Antitrust Commission imposed sanctions exceeding MXN 500 million on real estate companies including Grupo Danhos, GICSA, Liverpool, Acosta Verde, Chedraui, DMI, and ARYBA for allegedly coordinating discount terms offered to shopping centre tenants during the COVID-19 pandemic.
Poland’s competition authority, UOKiK, opened antitrust proceedings against Dino Polska and four transport companies over a suspected no-poach arrangement restricting the hiring of truck drivers across firms.
The European Commission opened a formal antitrust investigation into whether Sanofi abused its dominant position by running a misleading campaign against rival flu vaccine Fluad, produced by CSL Seqirus, targeting healthcare professionals in France and Germany.
The EC also launched an in-depth investigation under the Foreign Subsidies Regulation into JD.com’s proposed acquisition of CECONOMY, the German consumer electronics retailer operating under the MediaMarkt, MediaWorld, and Saturn brands, with a decision expected by October 2, 2026.
Germany’s Federal Ministry for Economic Affairs and Energy published a draft bill for the 12th Amendment to its Competition Act, proposing increases to all three merger control turnover thresholds and introducing a fixed eight-year term for the Federal Cartel Office President, among other measures.